Neuroscience Antibodies & Assays Global Market Report 2022: Increasing Prevalence of Neurological Conditions Drives Sector
December 15, 2022 08:03 ET
|
Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Neuroscience Antibodies & Assays Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's...
Global Therapeutic Monoclonal Antibodies Market to Reach $1.07 Trillion by 2028 at an 18.6% CAGR
December 15, 2022 07:48 ET
|
Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Global Therapeutic Monoclonal Antibodies Market - Analysis By Source, Target, Indication, Route of administration, By Region, By Country: Market...
Natural Killer Cells Therapeutics Global Market Report 2022: Rise in Awareness about Immunotherapies Bolsters Sector
December 09, 2022 05:33 ET
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer...
Custom Antibody Service Global Market Report 2022: Advantages Across Wide Variety of Applications Fuels Adoption
November 30, 2022 08:23 ET
|
Research and Markets
Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The "Custom Antibody Service Market, by Service Type, by Product Type, by Source, by Application, by End Users, and by Region - Size, Share, Outlook, and...
Dyadic Reports Third Quarter 2022 Financial Results and Highlights Recent Company Developments
November 10, 2022 16:00 ET
|
Dyadic International, Inc.
Received regulatory approval from South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 clinical trial to demonstrate clinical safety and antibody response in humans for...
The Worldwide Monoclonal Antibodies in Veterinary Health Industry is Expected to Reach $2.6 Billion by 2030
November 08, 2022 06:28 ET
|
Research and Markets
Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies in Veterinary Health Market Share, Size, Trends, Industry Analysis Report, By Animal Type, By Application, By End-Use, By Region,...
Dyadic to Present at Upcoming Industry and Investor Events in November
November 07, 2022 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
$264 Worldwide Monoclonal Antibody Therapeutics Industry to 2027 - Featuring AbbVie, Amgen, Bayer and Biogen Among Others
November 01, 2022 05:28 ET
|
Research and Markets
Dublin, Nov. 01, 2022 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Therapeutics Market (2022-2027) by Source, End-Users, Applications, and Geography, Competitive Analysis and the Impact of...
Dyadic to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
October 27, 2022 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Dyadic Receives Regulatory Approval to Initiate Phase 1 Clinical Trial to Demonstrate Clinical Safety and Efficacy in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
October 27, 2022 09:04 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...